Clinical Trial Update: Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

This entry provides a status update on a Phase 3 trial evaluating androgen ablation with or without docetaxel for advanced prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: A.O.U. San Giovanni Battista di Torino, Italy | Conditions: Pain, Prostate Cancer | Phase 3 | Status: UNKNOWN